European Archives - Page 27 of 982 - European Medical Journal

No Survival Benefit for Chemoradiotherapy in Oesophageal Cancer

A new study comparing treatment strategies for stage T2N0M0 oesophageal cancer has revealed no significant survival advantage for patients receiving neoadjuvant chemoradiotherapy followed by surgery.

Nirmatrelvir/Ritonavir Alleviates COVID-19 Symptoms in High-Risk Patients

Nirmatrelvir/ritonavir reduced hospitalisations, symptom duration, and healthcare resource utilisation in high-risk, unvaccinated adults with mild-to-moderate COVID-19.

Could GLP-1 Drugs Reduce Alcohol Consumption?

A systematic review investigating the impact of glucagon-like peptide-1 receptor agonists on alcohol consumption has yielded some promising results.

Efficacy of Dupilumab in Children with Atopic Dermatitis

At week 16, dupilumab demonstrated significant benefits compared to placebo, regardless of the presence of asthma or AR.

Donald Trump picks last role in health leadership team

President-elect Donald Trump has picked the final post in his health team, selecting Dr Jay Bhattacharya to be Director of the US National Institutes of Health.

Systemic Inflammation Links Psoriasis Severity to Cardiovascular Disease

Systemic inflammation mediates psoriasis severity’s link to cardiovascular disease, highlighting its importance in clinical care.

Combining Therapies Boosts Survival in Bladder Cancer

Predictive biomarkers are expected to play a pivotal role in further enhancing treatment outcomes as they can identify patients at higher risk of recurrence.

Hema Now: Episode 5: The Hidden Impact of Blood Disorders on Brain Health

In this episode of Hema Now, Jonathan Sackier welcomes Christopher Patriquin, a leading expert in the field of hematology and rare diseases. With a wealth of experience in teaching, consulting, clinical research, and hosting excellent dinner parties, Patriquin’s discussion sheds light on many fascinating topics.

Nicotinamide Riboside Reduces Airway Inflammation in Patients With COPD

Nicotinamide riboside reduces airway inflammation and boosts NAD+ levels in COPD patients, study shows.

Climate Change Drives Increased Use of Medical Imaging in Emergency Departments

Study finds air pollution linked to increased use of medical imaging in emergency departments.